This project will see CCRM Australia accelerating the commercialization of Australian regenerative medicine technologies, therapies and related products.
CCRM will achieve this by fostering increased collaboration between industry, clinicians and academia, both locally and globally; and nurturing local regenerative medicine companies for the international market.
Visit CCRM Australia for more details.
Listen to our podcast to hear CCRM Australia CEO Silvio Tiziani talk about the project.
LinkedIn: CCRM Australia
|Consortium lead||Monash University|
|Consortium members||Australian Regenerative Medicine Institute (ARMI), CCRM (Canada), Bioplatforms Australia (BPA), Cell Therapy Manufacturing CRC, ReNerve Pty Ltd, Cynata Therapeutics Ltd, Regeneus Ltd & Australian Red Cross Blood Service|
|Project duration||January 2018 - October 2019|
|Contact||Silvio Tiziani, Monash University - email@example.com|